Market revenue in 2023 | USD 35.2 million |
Market revenue in 2030 | USD 53.9 million |
Growth rate | 6.3% (CAGR from 2023 to 2030) |
Largest segment | Logistics & distribution |
Fastest growing segment | Logistics & distribution |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Logistics & distribution, Storage & retention, Packaging, labeling and blinding, Manufacturing, Comparator sourcing, Other services (solutions, ancillary supply) |
Key market players worldwide | Thermo Fisher Scientific Inc, Catalent Inc, PAREXEL, Almac Group, Piramal Pharma Solutions, DHL Group, FedEx Corp, UDG Healthcare, Marken, Walden Group, PCI Pharma Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial supply & logistics market will help companies and investors design strategic landscapes.
Logistics & distribution was the largest segment with a revenue share of 25.28% in 2023. Horizon Databook has segmented the Colombia clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
For over 25 years, clinical trials have been conducted in Colombia, and it is one of the best destinations for clinical trials, along with Brazil, Argentina, Mexico, and Peru. However, majority of the country’s clinical research sites do not have direct contact with foreign manufacturers, especially with startup players that need to perform early stage (phase I) trials for new pharmaceutical molecules.
Large number of clinical trials are sponsored by players that discover or manufacture such medical products so that they can be approved for commercialization by regulatory bodies in markets where they seek to conduct business.
The company is able to provide medical devices and biopharmaceutical industries with high enrollment rate, competitive costs, regulatory efficiency by Instituto Nacional de Vigilancia de Medicamentos (INVIMA), highly qualified & motivated bilingual researchers, and ideal geographical area with direct and fast airline connectivity from prime centers of innovation in Europe. and the U.S.
Horizon Databook provides a detailed overview of country-level data and insights on the Colombia clinical trial supply & logistics market , including forecasts for subscribers. This country databook contains high-level insights into Colombia clinical trial supply & logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account